X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare PLETHICO PHARMA with Pfizer - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PLETHICO PHARMA vs PFIZER - Comparison Results

PFIZER 
   Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PLETHICO PHARMA PFIZER PLETHICO PHARMA/
PFIZER
 
P/E (TTM) x -1.1 24.6 - View Chart
P/BV x 0.0 3.9 0.4% View Chart
Dividend Yield % 0.0 0.8 -  

Financials

 PLETHICO PHARMA   PFIZER
EQUITY SHARE DATA
    PLETHICO PHARMA
Mar-14
PFIZER
Mar-16
PLETHICO PHARMA/
PFIZER
5-Yr Chart
Click to enlarge
High Rs3952,724 14.5%   
Low Rs311,611 1.9%   
Sales per share (Unadj.) Rs604.4440.9 137.1%  
Earnings per share (Unadj.) Rs32.548.7 66.7%  
Cash flow per share (Unadj.) Rs51.375.8 67.7%  
Dividends per share (Unadj.) Rs015.00 0.0%  
Dividend yield (eoy) %00.7 0.0%  
Book value per share (Unadj.) Rs473.6462.9 102.3%  
Shares outstanding (eoy) m34.0845.75 74.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.44.9 7.2%   
Avg P/E ratio x6.644.5 14.7%  
P/CF ratio (eoy) x4.228.6 14.5%  
Price / Book Value ratio x0.54.7 9.6%  
Dividend payout %030.8 0.0%   
Avg Mkt Cap Rs m7,26299,163 7.3%   
No. of employees `000NA2.9 0.0%   
Total wages/salary Rs m1,5962,758 57.9%   
Avg. sales/employee Rs ThNM6,981.7-  
Avg. wages/employee Rs ThNM954.5-  
Avg. net profit/employee Rs ThNM771.1-  
INCOME DATA
Net Sales Rs m20,59820,170 102.1%  
Other income Rs m386857 45.1%   
Total revenues Rs m20,98421,028 99.8%   
Gross profit Rs m2,8184,310 65.4%  
Depreciation Rs m6421,239 51.9%   
Interest Rs m1,5935 30,638.5%   
Profit before tax Rs m9693,923 24.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m099 0.0%   
Tax Rs m-1381,794 -7.7%   
Profit after tax Rs m1,1072,228 49.7%  
Gross profit margin %13.721.4 64.0%  
Effective tax rate %-14.345.7 -31.2%   
Net profit margin %5.411.0 48.7%  
BALANCE SHEET DATA
Current assets Rs m18,87716,299 115.8%   
Current liabilities Rs m11,8967,594 156.7%   
Net working cap to sales %33.943.2 78.5%  
Current ratio x1.62.1 73.9%  
Inventory Days Days3665 55.1%  
Debtors Days Days19826 768.2%  
Net fixed assets Rs m9,8618,622 114.4%   
Share capital Rs m341458 74.5%   
"Free" reserves Rs m12,33120,722 59.5%   
Net worth Rs m16,13921,180 76.2%   
Long term debt Rs m4,70625 18,823.2%   
Total assets Rs m33,14629,137 113.8%  
Interest coverage x1.6755.5 0.2%   
Debt to equity ratio x0.30 24,703.1%  
Sales to assets ratio x0.60.7 89.8%   
Return on assets %8.17.7 106.3%  
Return on equity %6.910.5 65.2%  
Return on capital %12.319.0 64.7%  
Exports to sales %21.40.1 35,924.7%   
Imports to sales %15.217.5 87.1%   
Exports (fob) Rs m4,40212 36,686.7%   
Imports (cif) Rs m3,1363,526 88.9%   
Fx inflow Rs m4,40252 8,523.5%   
Fx outflow Rs m3,184140 2,274.5%   
Net fx Rs m1,219-88 -1,379.5%   
CASH FLOW
From Operations Rs m2,4373,436 70.9%  
From Investments Rs m-6,265-6,991 89.6%  
From Financial Activity Rs m2,490-619 -402.4%  
Net Cashflow Rs m-1,337-4,174 32.0%  

Share Holding

Indian Promoters % 82.7 0.0 -  
Foreign collaborators % 0.0 63.9 -  
Indian inst/Mut Fund % 4.3 7.5 57.3%  
FIIs % 5.5 4.9 112.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 7.5 23.7 31.6%  
Shareholders   10,665 85,207 12.5%  
Pledged promoter(s) holding % 85.7 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PLETHICO PHARMA With:   MERCK LTD  STERLING BIOTECH  JUBILANT LIFE SCIENCES  AUROBINDO PHARMA  IPCA LABS  

Compare PLETHICO PHARMA With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Bank & Realty Stocks Rally(Closing)

Indian share markets surged further in the afternoon session and finished in the green for the second straight session on heavy buying in realty stocks, metal stocks and bank stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

The Most Important Innovation in Finance Since Gold Coins(Vivek Kaul's Diary)

Aug 10, 2017

Bill connects the dots...between money and growth, real money and real resources, gold and cryptocurrencies...and between gold, cryptocurrencies, and time.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PLETHICO PHARMA SHARE PRICE


Jun 13, 2016 (Close)

TRACK PLETHICO PHARMA

  • Track your investment in PLETHICO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PLETHICO PHARMA

PLETHICO PHARMA - CADILA HEALTHCARE COMPARISON

COMPARE PLETHICO PHARMA WITH

MARKET STATS